BioDelivery Sciences International Inc. (BDSI)

6.18
0.03 0.48
NASDAQ : Health Technology
Prev Close 6.21
Open 6.26
Day Low/High 6.08 / 6.26
52 Wk Low/High 2.80 / 6.45
Volume 904.00K
Avg Volume 969.60K
Exchange NASDAQ
Shares Outstanding 89.91M
Market Cap 552.96M
EPS -0.70
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Interesting BDSI Put And Call Options For June 2020

Interesting BDSI Put And Call Options For June 2020

Investors in BioDelivery Sciences International Inc saw new options become available this week, for the June 2020 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 241 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

BioDelivery Sciences Announces Significant Additional Insurance Coverage For Both BELBUCA® And Symproic®

BioDelivery Sciences Announces Significant Additional Insurance Coverage For Both BELBUCA® And Symproic®

Major Pharmacy Benefit Manager (PBM) Improves Access for Both Products to Approximately 14 Million Lives Symproic Will be Listed as Preferred Exclusive and BELBUCA Preferred or Preferred Exclusive RALEIGH, N.

BDSI Makes Notable Cross Below Critical Moving Average

BDSI Makes Notable Cross Below Critical Moving Average

In trading on Friday, shares of BioDelivery Sciences International Inc crossed below their 200 day moving average of $4.41, changing hands as low as $4.30 per share. BioDelivery Sciences International Inc shares are currently trading down about 3.8% on the day.

3 Small Biotechs With Favorable Risk Vs. Reward Profiles

3 Small Biotechs With Favorable Risk Vs. Reward Profiles

BioDelivery Sciences International, Chiasma Inc. and TherapeticsMD all feature promising treatments.

BioDelivery Sciences Announces Five Medical Abstracts Accepted At PAINWeek® 2019 National Conference On Pain Management

BioDelivery Sciences Announces Five Medical Abstracts Accepted At PAINWeek® 2019 National Conference On Pain Management

New Scientific Information Further Highlights Clinical Profiles of BELBUCA® and Symproic®

Bullish Two Hundred Day Moving Average Cross - BDSI

Bullish Two Hundred Day Moving Average Cross - BDSI

In trading on Friday, shares of BioDelivery Sciences International Inc crossed above their 200 day moving average of $4.28, changing hands as high as $4.40 per share. BioDelivery Sciences International Inc shares are currently trading up about 6.7% on the day.

BioDelivery Sciences Reports Strong Second Quarter 2019 Results And Raises Net Sales Expectations

BioDelivery Sciences Reports Strong Second Quarter 2019 Results And Raises Net Sales Expectations

BELBUCA® Net Sales Increased 147% versus Prior Year to All-Time High of $24.1 Million Raises Full-Year BELBUCA Net Sales Expectations to $90 - $93 Million Raises Full-Year Total Company Net Sales Expectations to $101 - $105 Million Raises Long-Term...

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating BioDelivery Sciences International, Inc. For Potential Breaches Of Fiduciary Duty By Its Board Of Directors

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating BioDelivery Sciences International, Inc. For Potential Breaches Of Fiduciary Duty By Its Board Of Directors

NEW YORK, July 29, 2019 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of BioDelivery...

3 Small-Caps That Look Like Bargains at Current Trading Levels

3 Small-Caps That Look Like Bargains at Current Trading Levels

The trio consists of BioDelivery Sciences International, Beazer Homes USA and Redhill Biopharma.

BioDelivery Sciences Announces Further Improved Insurance Coverage For BELBUCA®

BioDelivery Sciences Announces Further Improved Insurance Coverage For BELBUCA®

Regional Commercial Plans Improved Access for More Than 6 Million Lives During 2Q More Than 90% of Commercial Lives Now Have Access to BELBUCA in the U.

These Two Small-Cap Stocks Are Executing Well

These Two Small-Cap Stocks Are Executing Well

Both Digital Turbine and BioDelivery Sciences have done well in 2019.

BioDelivery Sciences International Is Now Oversold (BDSI)

BioDelivery Sciences International Is Now Oversold (BDSI)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Here's How I'm Playing an Increasingly Volatile Market With These 2 Biotechs

Here's How I'm Playing an Increasingly Volatile Market With These 2 Biotechs

I am incrementally using buy-write option orders to add some shares to core holdings.

These 3 Biotech Stocks Are Moving Closer to Profitability

These 3 Biotech Stocks Are Moving Closer to Profitability

Here are updates on small biotech/biopharma names I have profiled before.

Interesting BDSI Put And Call Options For May 17th

Interesting BDSI Put And Call Options For May 17th

Investors in BioDelivery Sciences International Inc saw new options begin trading this week, for the May 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the BDSI options chain for the new May 17th contracts and identified one put and one call contract of particular interest.

My Post-Earnings Assessment of 2 Biotech Stocks

My Post-Earnings Assessment of 2 Biotech Stocks

Let's look at a couple of companies we have covered on these pages before.

3 Small Biotechs to Watch as Earnings Season Winds Down

3 Small Biotechs to Watch as Earnings Season Winds Down

One already is up nicely on its results, while the other two should issue reports of interest in the next few days.

Here Are 3 Small-Cap Names for Biotech Investors to Consider

Here Are 3 Small-Cap Names for Biotech Investors to Consider

We look at a slightly riskier part of the sector...that should be able to reach profitability with little to no additional funding needs.

3 Small Biotechs That Came Up Big on Thursday

3 Small Biotechs That Came Up Big on Thursday

Portola Pharmaceuticals, Flexion Therapeutics and BioDelivery Sciences delivered nice third-quarter numbers.

3 Small Biotechs Turn on the Revenue Jets

3 Small Biotechs Turn on the Revenue Jets

BioDelivery Sciences, Neos Therapeutics and Invitae Corp. are delivering big increases in sales.

TheStreet Quant Rating: D (Sell)